REMIBRUTINIB FOR USE IN THE TREATMENT OF HIDRADENITIS SUPPURATIVA Application WO-2023161887-A1 World Intellectual Property Organisation (WIPO) 31 Aug 2023
METHODS OF TREATMENT USING LOU064 Application WO-2023111802-A1 World Intellectual Property Organisation (WIPO) 22 Jun 2023
LOU064 FOR TREATING MULTIPLE SCLEROSIS Application WO-2023031840-A1 World Intellectual Property Organisation (WIPO) 09 Mar 2023
Preparation and application of indole compound BTK inhibitor Application CN-114853723-A China 05 Aug 2022